US Patent 10214586 PD-L1 antibodies
Patent 10214586 was granted and assigned to Eli Lilly and Company on February, 2019 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 10214586 PD-L1 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
